OpGen updated on Curetis Now Offering BGI’s CE-IVD rapid test kit for Coronavirus in Europe
On Mar. 16, 2020, OpGen reported an update on the business of Curetis, the other party to the…
On Mar. 16, 2020, OpGen reported an update on the business of Curetis, the other party to the…
On Mar. 16, 2020, Sanofi and Regeneron Pharma announced they have started a clinical program evaluating Kevzara (sarilumab)…
On Mar. 15, 2020, the National Institutes of Health (NIH) informed its staff that it had its first…
On Mar. 15, 2020, CureVac announced that internal efforts will be focused on the development of a coronavirus…
On Mar. 15, 2020, Fosun Pharma and BioNTech announced a strategic development and commercialization collaboration to advance BioNTech’s…
On Mar. 14, 2020, CureVac announced positive pre-clinical results at a low dose for its lead vaccine candidate…
On Mar. 13, 2020, Iceland health authorities and deCode Genetics announced they began comprehensive screening for the virus…
On Mar. 13, 2020, Enanta Pharmaceuticals announced it had initiated a program to discover direct-acting antiviral drug candidates…
On Mar. 13, 2020, IDEXX Laboratories announced the company had seen no positive results in pets to date…
On Mar. 13, 2020, BioReference Laboratories, an OPKO company, announced it had begun accepting specimens for testing of…
On Mar. 13, 2020, Luminex announced that four independent clinical laboratories had validated laboratory developed tests (LDTs) for…
On Mar. 13, 2020, PATH and the Centers for Disease Control and Prevention (CDC) announced a collaboration with…
On Mar. 12, 2020, Pluristem Therapeutics announced it a collaborative agreement with the BIH Center for Regenerative Therapy…
On Mar. 12, 2020, Vir Biotech announced it had signed a letter of intent with Biogen for the…
On Mar. 12, 2020, Emory University announced it was participating in a National Institutes of Health (NIH) sponsored…
On Mar. 12, 2020, the Mayo Clinic announced it had developed a test that can detect the SARS-CoV-2…
On Mar. 11 2020, the World Health Organization declared the Coronavirus outbreak a global pandemic. To-date, of the…
On Mar. 11, 2020, bioMerieux announced the forthcoming launch of 3 different tests to address the COVID-19 epidemic…
On Mar. 10, 2020, Innovation Pharma announced that management was advised that testing of Brilacidin, the Company’s flagship…
On Mar. 10, 2020, BCerTest Biotec, along with BD (Becton, Dickinson and Company) announced that the VIASURE SARS-CoV-2…
On Mar. 9, 2020, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the…
On Mar. 9, 2020, MediciNova announced that it planned to initiate development of MN-166 (ibudilast) for severe pneumonia…
On Mar. 9, 2020, Humanigen announced that it was actively exploring clinical stage strategies and partnerships to evaluate…
On Mar. 9, 2020, Winship Cancer Institute’s multiple myeloma team was awarded a $5 million grant from The…
On Mar. 6, 2020, the FDA approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease who either…
On Mar. 6, 2020, the Government of Canada announced an investment of nearly $27 million to fund Coronavirus…
On Mar. 6, 2020, University of British Columbia (UBC) researchers Yue Qian, Dr. Richard Lester, Dr. Srinivas Murthy,…
On Mar. 6, 2020, Mount Sinai Health System and Harbour BioMed (HBM) announced a multi-year, multifaceted collaboration to…
On Mar. 5, 2020, a $100 million government investment was announced that helped hospitals across the province upgrade…
On Mar. 5, 2020, in a study of epilepsy patients, researchers at the National Institutes of Health (NIH)…